Wang Kai, Kang Siru, Guan Yunfei, Tan Yunbo. Clinical Research of Thyroid Malignant Tumor among Han and Bai Nationality in Dali[J]. , 2017, 2(4): 52-55.
〔1〕哈斯也提·木明.Galectin-3、CD44v6在滤泡上皮起源甲
状腺肿瘤中的表达及意义〔D〕. 乌鲁木齐:新疆医科大
学,2008.
〔2〕孙嘉伟,许晓君,蔡秋茂,等.中国甲状腺癌发病趋势分
析〔J〕.中国肿瘤,2013,22(9):690-693.
〔3〕李卫东,刘冬梅,何洪芹,等.甲状腺癌诊断治疗及预后
因素的分析〔J〕.医护论坛,2011,18(34):178-179.
〔4〕杨刚. 66例老年人甲状腺癌外科治疗及预后分析〔J〕.当
代医学,2011,17(6):79.
〔5〕赵建新,张弛,刘荫华,等. 120例分化型甲状腺癌随访8
年的预后因素分析〔J〕.中国癌症杂志,2013,23(1):51-
54.
〔6〕汤建林,张永燕,马旭,等.大理地区妊娠期特异的甲状
腺功能正常参考值及临床意义〔J〕. 大理学院学报,
2015,14(10):45-48.〔7〕RICARTE-FILHO J,GANLY I,RIVERA M,et al. Papil?
lary thyroid carcinomas with cervical lymph node metasta?
ses can be stratified into clinically relevant prognostic cate?
gories using oncogenic BRAF,the number of nodal metasta?
ses,and extra-nodal extension〔J〕.Thyroid,2012,22(6):
575-584.
〔8〕CRAMER J D,FU P,HARTH K C,et al. Analysis of the ris?
ing incidence of thyroid cancer using the Surveillance〔J〕.
Surgery,2011,148:1147-1153.
〔9〕PELLEGRITI G,FRASCA F,REGALBUTO C,et al. World?
wide increasing incidence of thyroid cancer:update on epi?
demiology and risk factors〔J〕. J Cancer Epidemiol,2013,7:
212.
〔10〕罗胜兰,俞敏,龚巍巍.甲状腺癌的流行现况及其危险
因素〔J〕.中国预防医学杂志,2013,14(4):317-320.
〔11〕LOH K C. Familial nonmedullary thyroid carcinoma:a me?
ta-review of case series〔J〕. Thyroid,1997,7:107-113.
〔12〕徐静,李婷婷,陈光,等.1018例甲状腺癌临床病理分
析〔J〕.中华普通外科杂志,2011,26(4):279-282.
〔13〕COOPER D S,DOHERTY G M. Revised American Thy?
roid Association management guidelines for patients with
thyroid nodules and differentiated thyroid cancer〔J〕. Thy?
roid,2009,19(11):1167-1214.
〔14〕刘玉琴,张书全,陈万青,等.中国2003-2007年甲状腺
癌发病死亡现状及流行趋势分析〔J〕.中华流行病学杂
志,2012,33(10):1044-1048.
〔15〕KITAHARA C M,PLATZ E A,LAURA E,et al. Obesity
And thyroid cancer risk among U. S. men and women:a
pooled analysis of five prospective studies〔J〕. Cancer Epi?
demiol Biomarkers Prey,2011,20:464-472.